Challenges include vaccine mismatches resulting from the virus’ rapid evolution and resistance to antiviral drugs, and prevention is complicated by vaccine hesitancy and other factors.
Collaboration is crucial for optimizing care and addressing medication-access issues for patients with this chronic inflammatory disease of the spine.
Pharmacists can provide education about these medications to patients, physicians, and other pharmacists, and they can improve patient care by navigating various obstacles that can hinder access.
HEPLISAV-B™